Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Correction and Extension of Comment Period

This Proposed Rule document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder


Content

View document:
 
 
Comment Period Closed
Mar 13 2014, at 11:59 PM ET
ID: FDA-2013-N-0500-0006

Document Information

Date Posted: Dec 27, 2013
RIN: 0910-AG94
CFR: 21 CFR Parts 314 and 601
Federal Register Number: 2013-30881
Show More Details  

Comments

113
Comments Received*
FDA-2013-N-0500 RIN 0910-AG94 I support the FDA's proposed rule revision to better protect the public' health and safety. Undoubtedly most...
See Attached
See attached comments on Proposed Rule on labeling of drug and biological products.

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.